Genetics of melatonin receptor type 2 is associated with left ventricular function in hypertensive patients treated according to guidelines

Genetics of MTNR1B point to impact of the melatonin signalling pathway for BP and left ventricular function. This may support the importance of the melatonin system as a potential therapeutic target.